Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))

Beste Mutlu, Kfir Sharabi, Jee Hyung Sohn, Bo Yuan, Pedro Latorre-Muro, Xin Qin, Jin Seon Yook, Hua Lin, Deyang Yu, João Paulo G. Camporez, Shingo Kajimura, Gerald I. Shulman, Sheng Hui, Theodore M. Kamenecka, Patrick R. Griffin, Pere Puigserver*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

(Cell Chemical Biology 31, 1772–1786.e1–e5; October 17, 2024) Author B.M. is an employee of Elsevier, the publisher of Cell Chemical Biology, in the role of scientific editor for Developmental Cell. This article was written before the author was employed by Elsevier, and the author had no role in the editorial evaluation, peer-review process, or decision to accept the article. The article has been updated online to disclose this information.

Original languageEnglish
Pages (from-to)379
Number of pages1
JournalCell Chemical Biology
Volume32
Issue number2
DOIs
StatePublished - 20 Feb 2025

Bibliographical note

Publisher Copyright:
© 2025 Elsevier Ltd

Fingerprint

Dive into the research topics of 'Erratum: Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation (Cell Chemical Biology (2024) 31(10) (1772–1786.e5), (S2451945624003933), (10.1016/j.chembiol.2024.09.001))'. Together they form a unique fingerprint.

Cite this